𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Using Cost-Effectiveness Analysis to Define a Breast Cancer Benefits Package for the Uninsured

✍ Scribed by Jennifer L. Malin; Emmett Keeler; Cynthia Wang; Robert Brook

Book ID
110345886
Publisher
Springer US
Year
2002
Tongue
English
Weight
104 KB
Volume
74
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cost-effectiveness analysis of trastuzum
Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer
✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 209 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t